Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Si-Da Liao"'
Autor:
Xiao-Chun Yang, Shi-Jing Qian, Li Wang, Si-Da Liao, Ji Cao, Yong-Zhou Hu, Qiao-Jun He, Hong Zhu, Bo Yang
Publikováno v:
Translational Oncology, Vol 6, Iss 1, Pp 75-82 (2013)
A novel VP-16 derivative, 4β-[N -(4‴-acetyloxyl-phenyl-1‴-carbonyl)-4″-aminoanilino]-4′-O-demethyl-4-desoxypodophyllotoxin (GL3), displayed a wide range of cytotoxicity in a panel of human tumor cell lines, with half-maximal inhibitory conce
Externí odkaz:
https://doaj.org/article/a8e7dbe1fef94dbc9bdb59c0dda0d158
Autor:
Hong Zhu, Wei Yang, Ling-juan He, Wan-jing Ding, Lin Zheng, Si-da Liao, Ping Huang, Wei Lu, Qiao-jun He, Bo Yang
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e52333 (2012)
The human hepatocellular carcinoma (HCC) represents biologically aggressive and chemo-resistant cancers. Owing to the low affinity with the apoptotic factor Mcl-1, the BH3 mimetic drug ABT-737 failed to exert potent cancer-killing activities in varie
Externí odkaz:
https://doaj.org/article/b3ca7aa08c43463eaefeca5d1e3e0fd0
Autor:
Yijie Wang, Rong Dong, Zibo Chen, Hong Zhu, Renhua Gai, Guanyu Lin, Bo Yang, Si-Da Liao, Qiaojun He, Yongchuan Gu
Publikováno v:
European Journal of Pharmacology. 729:45-53
Epithelial-mesenchymal transition (EMT) is regarded as the most important mechanism behind the initiation of cancer metastasis. Though there has been great interest in developing therapies aimed at impairing the process of EMT, only few molecules hav
Autor:
Si-Da Liao, Yongzhou Hu, Li Wang, Ji Cao, Xiaochun Yang, Shijing Qian, Hong Zhu, Qiaojun He, Bo Yang
Publikováno v:
Translational Oncology, Vol 6, Iss 1, Pp 75-82 (2013)
A novel VP-16 derivative, 4β-[N -(4‴-acetyloxyl-phenyl-1‴-carbonyl)-4″-aminoanilino]-4′-O-demethyl-4-desoxypodophyllotoxin (GL3), displayed a wide range of cytotoxicity in a panel of human tumor cell lines, with half-maximal inhibitory conce
Autor:
Lin-Lin Chang, Hong Zhu, Qiaojun He, Yingying Fu, Meidan Ying, Ji Cao, Jia-Jie Shi, Si-Da Liao, Jin-Jian Lu, Bo Yang, Xiuping Chen, Yunguang Tong
Publikováno v:
Free radical biologymedicine. 71
Dihydroartemisinin (DHA), one of the main metabolites of artemisinin and its derivatives, presents anti-cancer potential in vitro and in vivo. To explore the mechanisms of resistance toward DHA, a DHA-resistant cell line, HeLa/DHA, was established wi